Plant-Derived Antimicrobial Peptides as Potential Antiviral Agents in Systemic Viral Infections.
Reads0
Chats0
TLDR
In this article, a literature review highlights studies including clinical trials which demonstrated that plant cyclotides have the ability to inhibit the growth of viruses causing human diseases, defensin-like peptides possess anti-HIV-1 activity and lipid transfer proteins and some lectins exhibit a varied antimicrobial profile.Abstract:
Numerous studies have led to a better understanding of the mechanisms of action of viruses in systemic infections for the development of prevention strategies and very promising antiviral therapies. Viruses still remain one of the main causes of human diseases, mainly because the development of new vaccines is usually challenging and drug resistance has become an increasing concern in recent decades. Therefore, the development of potential antiviral agents remains crucial and is an unmet clinical need. One abundant source of potential therapeutic molecules are plants: they biosynthesize a myriad of compounds, including peptides which can have antimicrobial activity. Our objective is to summarize the literature on peptides with antiviral properties derived from plants and to identify key features of these peptides and their application in systemic viral infections. This literature review highlights studies including clinical trials which demonstrated that plant cyclotides have the ability to inhibit the growth of viruses causing human diseases, defensin-like peptides possess anti-HIV-1 activity, and lipid transfer proteins and some lectins exhibit a varied antimicrobial profile. To conclude, plant peptides remain interesting to explore in the context of emerging and re-emerging infectious diseases.read more
Citations
More filters
Journal ArticleDOI
The Updated Review on Plant Peptides and Their Applications in Human Health
Saiprahalad Mani,Smruti B. Bhatt,Vinduja Vasudevan,Dhamodharan Prabhu,Sundaraj Rajamanikandan,Palaniyandi Velusamy,Palaniappan Ramasamy,P Janaki Raman +7 more
TL;DR: In this article , the status of various therapeutic plant peptides and their prospective status as peptide-based drugs for multiple diseases (infectious and non-infectious) is discussed.
Journal ArticleDOI
Efficacy and safety of add-on Viola odorata L. in the treatment of COVID-19: A randomized double-blind controlled trial
Mohammad Sadegh Adel Mehraban,Meysam Shirzad,Leila Mohammad Taghizadeh Kashani,Mohammad Mahdi Ahmadian-Attari,Ali Asghar Safari,Narges Ansari,Hossein Hatami,Mohammad Kamalinejad +7 more
TL;DR: A randomized parallel-group double-blind controlled trial was conducted at Al-Zahra general hospital, Isfahan, Iran to evaluate the efficacy of sweet violet syrup in alleviating the manifestations of COVID-19 infection as discussed by the authors .
Journal ArticleDOI
Crosstalk of nitro-oxidative stress and iron in plant immunity.
TL;DR: In this article , the authors focused on advances in recent knowledge related to the role of reactive oxygen species (ROS) and RNS, and association of these signaling molecules with iron in plant immunity.
Journal ArticleDOI
Therapeutic Potential of Marine Bioactive Peptides against Human Immunodeficiency Virus: Recent Evidence, Challenges, and Future Trends
Jameel M. Al-Khayri,Waqas Asghar,Sipper Khan,Aqsa Akhtar,Haris Ayub,Nauman Khalid,Fatima Mohammed Alessa,Muneera Q. Al-Mssallem,Adel A. Rezk,Wael Fathi Shehata +9 more
TL;DR: The present review summarizes the recent developments regarding bioactive peptides sourced from various marine organisms and offers insight into the future trends with an emphasis on the potential of exploration and evaluation of novel peptides to be developed into effective antiretroviral drugs.
Journal ArticleDOI
Improved Database Filtering Technology Enables More Efficient Ab Initio Design of Potent Peptides against Ebola Viruses
Thomas Ripperda,Yangsheng Yu,Atul Verma,Elizabeth Klug,Michellie Thurman,St. Patrick Reid,Guanghui Wang +6 more
TL;DR: An improved database filtering technology is presented for a more effective design of novel antiviral agents, with broad antiviral activity, that may selectively disrupt viral envelopes and offer the lasting efficacy required to treat various RNA viruses, including their emerging mutants.
References
More filters
Journal ArticleDOI
Coronavirus biology and replication: implications for SARS-CoV-2.
TL;DR: The first discoveries that shape the current understanding of SARS-CoV-2 infection throughout the intracellular viral life cycle are summarized and relate that to the knowledge of coronavirus biology.
Journal ArticleDOI
Foot-and-Mouth Disease
Marvin J. Grubman,Barry Baxt +1 more
TL;DR: The reemergence of FMD in developed countries that had been disease free for many years is described and the effect that this has had on disease control strategies is described.
Journal ArticleDOI
Structure of dengue virus: implications for flavivirus organization, maturation, and fusion.
Richard J. Kuhn,Wei Zhang,Michael G. Rossmann,Sergei V. Pletnev,Jeroen Corver,Edith M. Lenches,Christopher T. Jones,Suchetana Mukhopadhyay,Paul R. Chipman,Ellen G. Strauss,Timothy S. Baker,James H. Strauss +11 more
TL;DR: The first structure of a flavivirus has been determined by using a combination of cryoelectron microscopy and fitting of the known structure of glycoprotein E into the electron density map, suggesting that flaviviruses employ a fusion mechanism in which the distal beta barrels of domain II of the glycop Protein E are inserted into the cellular membrane.
Journal ArticleDOI
Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis.
Silvia de Sanjosé,Mireia Diaz,Xavier Castellsagué,Gary M. Clifford,Laia Bruni,Nubia Muñoz,F. Xavier Bosch +6 more
TL;DR: The HPV types most commonly detected are similar to those most commonly described in pre-neoplastic and cancer cases, although the relative contribution of HPV16 and HPV18 is substantially lower in cytologically normal women.
Journal ArticleDOI
Lassa fever. Effective therapy with ribavirin.
Joseph B. McCormick,Isabel J. King,Patricia A. Webb,Curtis L. Scribner,R. B. Craven,Karl M. Johnson,Luanne H. Elliott,R. Belmont-Williams +7 more
TL;DR: It is concluded that ribavirin is effective in the treatment of Lassa fever and that it should be used at any point in the illness, as well as for postexposure prophylaxis.